Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01E Fractional Dose Schedule in Children
NCT03276962Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2017
- Primary completion
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of RTS,S in malaria (5 arms), sponsored by GSK. Primary endpoint: Incidence of Clinical Malaria Meeting the Primary Case Definition. Started Sep 2017; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03276962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03276962.